for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

JSR Corp

4185.T

Latest Trade

1,831.00JPY

Change

21.00(+1.16%)

Volume

875,500

Today's Range

1,797.00

 - 

1,836.00

52 Week Range

1,475.00

 - 

1,914.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

JSR Corp Says Will Establish A Wholly-Owned Subsidiary For Investment To Accelerate New Business Development Around Digital Technologies

Aug 20 (Reuters) - JSR Corp <4185.T>::JSR CORP - WILL ESTABLISH A WHOLLY-OWNED SUBSIDIARY FOR INVESTMENT TO ACCELERATE NEW BUSINESS DEVELOPMENT AROUND DIGITAL TECHNOLOGIES.JSR CORP - JSR ACTIVE INNOVATION FUND, LLC, TO LAUNCH ON OCT 1, 2019 & WILL INVEST GLOBALLY IN START-UP COMPANIES MAINLY FOCUSING ON DIGITAL TECHNOLOGY.JSR CORP - INVESTMENT BY JSR ACTIVE INNOVATION FUND LLC WILL BEGIN WITH INITIAL ROUND OF 3 BILLION YEN AND IS EXPECTED TO GROW UP TO 10 BILLION YEN.

JSR To Buy Back Up To 2.83 Percent Of Shares Worth 10 Billion Yen Through Sept 30

April 24 (Reuters) - JSR Corp <4185.T>::TO BUY BACK UP TO 2.83 PERCENT OF SHARES WORTH 10 BILLION YEN THROUGH SEPT 30.

JSR's Managing Officer Eric Johnson To Become CEO In June

March 14 (Reuters) - Japan's JSR Corp <4185.T>::MANAGING OFFICER ERIC JOHNSON TO BECOME CEO IN JUNE.CHANGING TOP MANAGEMENT STRUCTURE TO CREATE POSITIONS OF CEO AND COO.CHANGES AIMED AT IMPLEMENTING MANAGEMENT SYSTEM FROM BROADER PERSPECTIVE AS GLOBAL ECONOMY CONTINUES TO EXPAND AND BECOME MORE DIVERSE.

Selexis Expands Strategic Immuno-Oncology Alliance With Agenus

Jan 9 (Reuters) - Selexis SA::SELEXIS EXPANDS STRATEGIC IMMUNO-ONCOLOGY ALLIANCE WITH AGENUS.SELEXIS SA SAYS HAS SIGNED ADDITIONAL COMMERCIAL LICENSE AGREEMENTS WITH AGENUS.SELEXIS SA SAYS UNDER NEW LICENSE AGREEMENTS, AGENUS WILL LEVERAGE SELEXIS' MODULAR SURETECHNOLOGY PLATFORM FOR PRODUCTION OF ITS THERAPEUTIC PROTEINS.

Medical&Biological Laboratories announces result of early-retirement program

Nov 16(Reuters) - Medical&Biological Laboratories Co Ltd <4557.T>:Says 32 employees took up the offer of the early-retirement program announced on Sept. 28.Effective date of retirement is Dec. 31.

Medical&Biological Laboratories to offer early-retirement program

Sept 28(Reuters) - Medical&Biological Laboratories Co Ltd <4557.T>:Says it plans to offer an early-retirement program to employees, who are above 40 years old as of Oct. 1.Offering period from Nov. 1 to Nov. 15.The company expects 30 employees to take the offer.Says the employees who take up the offer will retire on Dec. 31.The company will provide retirement payment and outplacement support to the retiring employees.

R&I affirms JSR's rating at "AA-" and changes outlook to stable -R&I

Aug 13(Reuters) - JSR Corp <4185.T>:Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA-" -R&I.Rating outlook changes to stable from negative -R&I.

JSR Notice Regarding Purchase Of Treasury Stock

July 30 (Reuters) - JSR Corp <4185.T>::NOTICE REGARDING PURCHASE OF TREASURY STOCK.

JSR completes acquisition of Crown Bioscience International

May 31(Reuters) - JSR Corp <4185.T>:Says it completed acquisition of Crown Bioscience International <<<6554.TWO>>>.Acquisition plan was announced on Dec. 20, 2017 .

JSR's operating profit surge to about 10 bln yen in April-June quarter - Nikkei‍​

July 13 (Reuters) - Nikkei‍​::JSR Corp's operating profit surged to an estimated 10 billion yen in the April-June quarter - Nikkei‍​.JSR Corp's sales appear to have grown from 88.7 billion yen to around 100 billion yen for the April-June quarter - Nikkei.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up